In diabetes, foot ulcers are such a common complication that they account for almost 1% of the total NHS budget and can lead to amputations
COUR Pharmaceuticals has published details of a study with the Miller Lab at Northwestern University, in which treatment with the COUR NanoParticle Platform (CNP) prevented
Australia could become the first country to adopt routine childhood screening to detect Type 1 diabetes in children, if a new national screening research pilot
Type 2 diabetes is a well-established risk factor for dementia and Parkinson’s Disease (PD), but according to a report by Marlene Busko in Medscape, a
According to new research at the University of Chicago, the causes of Type 1 diabetes focus on auto-immune response, in which the immune system shatters
At the American Diabetes Association 82nd annual Scientific Sessions, Vertex Pharmaceuticals released new data from a trial of two participants receiving a stem cell-derived beta
The national Children and Young People’s Mental Health (CYPMH) Team at NHS England and Improvement are recruiting four national lived experience partners to work in
Research project seeks older Type 2s on insulin, an update. By Susannah Hickling. Researchers at King’s College London are stepping up recruitment of older people
It is known that obesity increases the risk of developing T2D but one in ten sufferers are not obese or overweight. Results from a study
A once-weekly 2mg injection of Novo Nordisk’s Ozempic semaglutide product Ozempic has been approved for use in America, following results of the SUSTAIN FORTE trial,
